日本呼吸器学会雑誌第45巻第2号

Similar documents



橡stat3.PDF

1 FEV1.0 FEV % NIH FEV % FEV1.0 50% FEV1.0 cyanosis PaO2 PaCO2 PaO2 PaCO2 40mmHg FEV1.0 25%


【知事入れ版】270804_鳥取県人口ビジョン素案

A

2

SD SD SD

アルコール依存症

Microsoft Word - aphj_slides pptx

第5回東京都廃棄物審議会

フィジカルコンディショニング

PowerPoint プレゼンテーション

支援リスト3/30.xls


広報しもつけp01ol

ONPRESS190




エンジョイ北スポーツ

エンジョイ北スポーツ

障害者職域拡大カリキュラム研究会中間報告書構成案

th近畿学術集会 抄録

終末期の呼吸困難症状への対応*松坂最終修正

エンジョイ北スポーツ


1 2

P.5 P.6 P.3 P.4 P.7 P.8 P.9 P.11 P.19

在宅呼吸ケア白書

NSIPとUCTD(HP用).ppt

3 ( 9 ) ( 13 ) ( ) 4 ( ) (3379 ) ( ) 2 ( ) 5 33 ( 3 ) ( ) 6 10 () 7 ( 4 ) ( ) ( ) 8 3() 2 ( ) 9 81



1 Q A 82% 89% 88% 82% 88% 82%

Fig. 1 Table l l l l l l l l l l l l l l l l l l l l l l l l l l

syougai

272 日本呼吸ケア リハビリテーション学会誌第 22 巻第 3 号 表 1 Variables Value Age, yr Sex Male 81 Female 12 Height, cm Body weight, kg 6

2 2 1?? 2 1 1, 2 1, 2 1, 2, 3,... 1, 2 1, 3? , 2 2, 3? k, l m, n k, l m, n kn > ml...? 2 m, n n m

‹Àfi¡‚¾”O/…_…C…W…F…X…g/01-01

untitled

福祉行財政と福祉計画[第3版]

日本呼吸器学会雑誌第44巻第10号

日本呼吸器学会雑誌第44巻第7号

2 (1) (2) SCI 2 SCI

スライド 1

1

「諸雑公文書」整理の中間報告

P.37 P.816 P.17 P.1819 contents 1 2

-51-

2006年3月8日



日本呼吸器学会雑誌第48巻第6号

取扱説明書 [F-08D]

橡●031222第2回環境・都市機能会議録【確定版】(0

Microsoft Word - 01マニュアル・入稿原稿p1-112.doc

tnbp59-21_Web:P2/ky132379509610002944

取扱説明書 [F-05E]

表 1 入院時検査所見 11,500L 471 L 17.0 gdl.3 L ph 7.49 PaCO 37.8 mmhg PaO 67.4 mmhg HCO 3.6 meql B E 1. meql 141 meql K 3.9 meql Cl 108 meql Ca 8.4 mgdl P 4.5

untitled

Z...QXD (Page 1)

Transcription:

ADL: Feeding Transfer Dressing Bathing IADL: Shopping Transportation Table1 Spector-KatzIndex * ADL-IADLisevaluatedbythesum ofeachscore(0:totaly dependent,6:totalyindependent) Table2 Generalcharacteristicsofthepatients Age(years) Male/Female Height(cm) BMI MRCscale BDIfocalscore GOLD stage PaO2 (Torr) PaCO2 (Torr) VC (ml) VC (% predicted) FEV1 (ml) FEV1 (% predicted) FEV1/FVC (%) 6MWD (m) ΔSpO2(%) Borgscaleafterthe6-minutewalk COPD (n=111) 70± 7 104:7 161± 7 19.7± 3.0 1-7,2-23,3-40,4-40,5-1 6.7± 1.9 I-2,I-21, I-45,IV-43 74.7± 11.1 *26caseswerebreathingoxygen. 43.7± 7.4 2,580± 840 81.5± 21.1 990± 480 37.3± 15.7 43.3± 11.2 368± 90-5.2± 4.2 3.9± 2.0 non-copd (n=93) 69± 6 69:24 159± 8 20.2±3.8 1-1,2-15,3-34,4-43 6.1±1.7 76.2± 10.8 *34caseswerebreathingoxygen. 47.0± 8.4 1,740± 790 58.1± 23.6 1,080± 570 41.2± 19.8 68.2± 18.5 352± 90-5.7± 4.7 4.4± 2.2 BMI:bodymassindex,BDI:BaselineDyspneaIndex,VC:vitalcapacity,FEV1:forcedexpiratoryvolumein1second, FVC:forcedvitalcapacity,6MWD:6-minutewalkingdistance,Δ SpO2:oxygendesaturationduringthe6-minutewalk.

Fig.1 ADL-IADLscore A:COPD group,b:non-copd group

Table3 Accuracyindeterminingthelevelthreerespiratoryhandicapsusingthecurrentcriteria A.A lcases 38 39 77 11 116 127 49 155 204 B.COPD 20 19 39 5 67 72 25 86 111 C.non-COPD 18 20 38 6 49 55 24 69 93 D.Interstitiallungdisease 4 0 4 2 13 15 6 13 19 Fig.2 SimplelogisticregressioncurvesshowingtherelationbetweenADL-IADLscoreandFEV1Index (A),and6-minutewalkingdistance(B)inpatientswithCOPD. TheY-axisindicatestheprobabilityofanADL-IADLscoreof4orless.Whenthe6-minutewalkingdistanceis270m,theprobabilityofanADL-IADLscoreof4orlessis50%.

Fig.3 Cross-tableanalysesbetweenADL-IADLscoreandGOLD stage(a),supplementaloxygenuse(b), andmrcscale(c)inpatientswithcopd.

Table4 MultivariatelogisticregressionmodelestimatinginpatientswithCOPD from thethreeselectedparameters Estimation SD χ 2 p 95% CI, upperlimitlowerlimit Oddsratio Intercept -3.108 0.881 5.73 0.0167-4.932-1.422 MRCgrade(1-3/4,5) 1.246 0.638 3.81 0.0509-0.005 2.538 3.475 6MWD (270m) -0.830 0.726 1.31 0.2527-2.280 0.609 0.436 Supplementaloxygen(+ /-) 2.617 0.602 18.89 <0.001 1.476 3.862 13.689 p< 0.0001,R 2 =0.341 Abbreviationsareshownintable1. Fig.4 SimplelogisticcurvesshowingtherelationbetweenADL-IADLscoreandFEV1index(A),and6- minutewalkingdistance(b)in patientswithnon-copd lungdisease. Y-axisindicatestheprobabilityofanADL-IADLscoreof4orless.When6-minutewalkingdistanceis255 m,theprobabilityofadl-iadlscoreof4orlessis50%. Fig.5 Cross-tableanalysesbetweenADL-IADLscoreandsupplementaloxygenuse(A),andMRCscale (B)inpatientswithnon-COPD lungdisease.

Table5 Multivariatelogisticregressionmodelestimatinginpatientswithnon-COPD lungdiseasefrom thethreeselectedparameters Estimation SD χ 2 p 95% CI, upperlimit lowerlimit Oddsratio Intercept -2.638 1.119 5.55 0.0185-5020 -0.481 MRCgrade(1-3/4,5) 2.650 0.8258 10.32 0.0013 1.201 4.589 14.148 6MWD (255m) -0.801 0.801 1.00 0.3175-2.504 0.723 0.449 Supplementaloxygen(+ /-) 1.083 0.613 3.12 0.0776-0.114 2.314 2.952 p< 0.0001,R 2 =0.328 Fig.6 SimplelogisticcurvesshowingtherelationbetweenADL-IADLscoreandFEV1Index(A),and6- minutewalkingdistance(b)inpatientswithinterstitiallungdisease. TheY-axisindicatestheprobabilityofanADL-IADLscoreof4orless.When6-minutewalkingdistance is280m,theprobabilityofanadl-iadlscoreof4orlessis50%. Fig.7 ROCcurves,FEV1Index(A)and6-minutewalkingdistance(B)

Table6 Accuracyindeterminingthelevelthreerespiratoryhandicapusingthenew criteria A.A lcases 40 30 70 9 125 134 49 155 204 B.COPD 18 15 33 7 71 78 25 86 111 C.non-COPD 22 15 37 2 54 55 24 69 93 D.Interstitiallungdisease 6 1 7 0 12 12 6 13 19 Table7 Predictiveabilityofthecurrentandnew criteriaforadl Sensitivity Specificity PPV NPV Overalaccuracy A lcases currentcriteria 77.6 74.8 46.4 91.3 75.5 new criteria COPD 81.6 80.7 57.1 93.3 80.9 currentcriteria 80.0 77.9 51.3 93.1 78.4 new criteria Non-COPD 72.0 82.6 54.6 91.0 80.2 currentcriteria 75.0 71.0 47.4 89.1 72.0 new criteria Interstitiallungdisease 91.7 78.3 56.5 96.4 81.7 currentcriteria 66.7 100 100 86.7 89.5 new criteria 100 92.3 85.7 100 94.7 PPV:positivepredictivevalue,NPV:negativepredictivevalue